Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-Cl C | Communication Services | 91,420.0 | $26.2M | 15.61% | — | — | $286.90 | +34.0% |
| 2 | APOS | Apollo Global Management, Inc. | Financial Services | 225,000.0 | $25.1M | 14.92% | — | — | $111.42 | -76.5% |
| 3 | SNDX | Syndax Pharmaceutical, Inc. | Healthcare | 422,000.0 | $9.9M | 5.87% | +7K | +1.7% | $23.36 | -14.7% |
| 4 | BBIO | Bridgebio Pharma, Inc. | Healthcare | 90,000.0 | $6.7M | 3.98% | +5K | +5.9% | $74.26 | -8.8% |
| 5 | PTGX | Protagonist Therapeutics, Inc | Healthcare | 63,000.0 | $6.6M | 3.95% | -10K | -13.7% | $105.40 | -4.9% |
| 6 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 1,060,000.0 | $6.1M | 3.66% | +90K | +9.3% | $5.80 | +7.7% |
| 7 | JPM | JPMorgan Chase & Co. | Financial Services | 19,477.0 | $5.7M | 3.41% | — | — | $294.16 | +4.0% |
| 8 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 1,600,000.0 | $5.6M | 3.34% | NEW | — | $3.51 | +15.6% |
| 9 | — | LPL Financial Holdings Inc. | — | 16,500.0 | $5.0M | 2.95% | NEW | — | $300.83 | — |
| 10 | JAAA | Janus Henderson AAA CLO ETF | — | 93,528.0 | $4.7M | 2.80% | — | — | $50.37 | +0.7% |
| 11 | ALKS | Alkermes PLC | Healthcare | 120,000.0 | $4.2M | 2.52% | +25K | +26.3% | $35.36 | +5.8% |
| 12 | TVTX | Travere Therapeutics, Inc. | Healthcare | 140,633.0 | $4.2M | 2.49% | -45K | -24.4% | $29.71 | +50.3% |
| 13 | COGT | Cogent Biosciences Inc. | Healthcare | 104,000.0 | $4.0M | 2.38% | +2K | +2.0% | $38.49 | -11.9% |
| 14 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 181,000.0 | $3.5M | 2.11% | +36K | +24.8% | $19.56 | -12.3% |
| 15 | AGIO | Agios Pharmaceutical, Inc. | Healthcare | 93,058.0 | $3.1M | 1.87% | +75K | +417.0% | $33.83 | -16.0% |
| 16 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 439,300.0 | $3.1M | 1.82% | NEW | — | $6.96 | +2.0% |
| 17 | TGTX | TG Therapeutics, Inc. | Healthcare | 90,001.0 | $3.0M | 1.78% | +45K | +100.0% | $33.22 | +20.5% |
| 18 | CPRX | Catalyst Pharmaceuticals, Inc. | Healthcare | 120,000.0 | $3.0M | 1.77% | -69K | -36.5% | $24.76 | +26.6% |
| 19 | ACLX | Arcellx Inc | Healthcare | 19,433.0 | $2.2M | 1.33% | -6K | -24.4% | $114.82 | +0.2% |
| 20 | XBI | SPDR S&P Biotech ETF | — | 15,000.0 | $1.9M | 1.14% | +2K | +15.4% | $127.74 | +4.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
58.3%
Financial Services
21.5%
Communication Services
17.3%
Technology
1.5%
Energy
0.6%
Consumer Defensive
0.3%
Basic Materials
0.2%
Real Estate
0.2%
Consumer Cyclical
0.1%
Industrials
0.1%